TLDR:
- Alumis led the biggest biotech funding round of the week with $259 million in Series C funding.
- Three out of the top five funding rounds were from biotech companies.
In the week of March 2 to 8, 2024, the top funding rounds in the U.S. were dominated by biotech companies. Alumis secured $259 million in Series C funding, making it the largest biotech raise of the year so far. Axonius, a cybersecurity and SaaS asset management startup, also saw a significant funding round with a $200 million Series E extension. Other notable biotech companies that received substantial funding included Sionna Therapeutics with $182 million in Series C, and Rakuten Medical with $119 million in Series E.
Additionally, Claroty, a security company, received $100 million in funding, while RapidSOS, a public safety company, raised $75 million. Overjet, an artificial intelligence dental platform, secured $53.2 million, and Dtex Systems, a cybersecurity company focused on insider threats, raised $50 million. Lastly, Argonaut Manufacturing Services, a manufacturing firm serving biopharma and life sciences industries, received $45 million in funding.
